Although there was no difference in CD64 expression between the tumour regions, the low-affinity-activating receptors CD32a and CD16 had significantly lower expression in the leading edge compared with the infiltrating zone and core (P < 0.001). The gene discussed is FCGR2A; the disease is neoplasm.